How Do Psychedelics Reduce Fear of Death?
Neuroethics May 17, 2024 DOI: 10.1007/s12152-024-09564-3 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Keywords | Psychedelics Spirituality Fear of death Death anxiety Metaphysical beliefs Neuroexistentialism |
| Citations | 14 |
| Key points | Argues that psychedelic experiences reduce fear of death mainly by promoting non-physicalist metaphysical beliefs, not by other proposed mechanisms. |
Abstract
Increasing evidence suggests that psychedelic experiences, undergone in controlled conditions, can have various durable psychological benefits. One such benefit is reductions in fear of death, which have been attested in both psychiatric patients and healthy people. This paper addresses the question: how, exactly, do psychedelic experiences reduce fear of death? It argues, against some prominent proposals, that they do so mainly by promoting non-physicalist metaphysical beliefs. This conclusion has implications for two broader debates: one about the mechanisms of psychedelic therapy, and one about the potential non-medical uses of psychedelics for the alleviation of existential angst in psychiatrically healthy people. On the first count, the paper argues that the role of metaphysical belief change in fear of death supports the “Relaxed Beliefs Under Psychedelics” (REBUS) model of psychedelic therapy over alternative accounts. On the second count, the paper argues that the role of metaphysical belief change undermines the proposed use of psychedelics in the “neuroexistentialist” project of naturalizing spirituality. The best available evidence suggests that when psychedelic experiences reduce existential angst and restore a sense of meaning in life, they do so primarily by persuading people of the falsity of a broadly naturalistic worldview, and thus do not help reconcile people to the truth of such a worldview.
Citations in the library
Cited by 13
- How to Change Minds Ethically: Doxastic Vulnerability, Epistemic Harm Reduction, and the Role of Therapists in Psychedelic Therapy Journal of Applied Philosophy October 24, 2025
- Exploring the role of psychedelic-assisted therapy in enhancing spirituality and mystical experiences in patients with life-threatening illnesses: A systematic review. Journal of Psychosomatic Research February 1, 2025
- The Role of Psychedelics in Contemporary Psychological and Interdisciplinary Inquiry. Journal of Personalized Medicine September 28, 2025
- Embracing Change: Impermanence Acceptance Mediates Differences in Death Processing Between Ayahuasca Users and Non-users July 28, 2024
- The Use of Psychedelics for Grief Following Death due to Advanced Illness: A Scoping Review. OMEGA - Journal of Death and Dying July 10, 2025
and 8 more in the library
Cites 30
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Archives of General Psychiatry September 7, 2010
- REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics Pharmacological Reviews June 20, 2019
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Psychopharmacology December 1, 2011
and 25 more in the library